Cargando…
Efficacy of Low-Dose Naltrexone and Predictors of Treatment Success or Discontinuation in Fibromyalgia and Other Chronic Pain Conditions: A Fourteen-Year, Enterprise-Wide Retrospective Analysis
Current pharmacologic treatments may provide limited analgesia in fibromyalgia and other chronic pain disorders. Low-dose naltrexone (LDN) has emerged as a potential analgesic option that has been minimally explored. This study aims to describe current real-world prescribing practices of LDN, to inv...
Autores principales: | Driver, C. Noelle, D’Souza, Ryan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135963/ https://www.ncbi.nlm.nih.gov/pubmed/37189705 http://dx.doi.org/10.3390/biomedicines11041087 |
Ejemplares similares
-
The Effects of Low Dose Naltrexone on Opioid Induced Hyperalgesia and Fibromyalgia
por: Jackson, Daniel, et al.
Publicado: (2021) -
The Safety and Efficacy of Low-Dose Naltrexone in Patients with Fibromyalgia: A Systematic Review
por: Yang, Juan, et al.
Publicado: (2023) -
Reduced Pro-Inflammatory Cytokines after Eight Weeks of Low-Dose Naltrexone for Fibromyalgia
por: Parkitny, Luke, et al.
Publicado: (2017) -
Depression in Fibromyalgia Patients May Require Low-Dose Naltrexone to Respond: A Case Report
por: Siembida, Jagoda, et al.
Publicado: (2022) -
Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial
por: Bruun, Karin Due, et al.
Publicado: (2021)